European Journal of Surgical Oncology
Volume 36, Issue 3 , Pages 244-250, March 2010

A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer

  • V. Velenik

      Affiliations

    • Department of Radiotherapy, Institute of Oncology, Ljubljana, Slovenia
    • Corresponding Author InformationCorresponding author. Institute of Oncology, Zaloška cesta 2, 1000 Ljubljana, Slovenia. Tel.: +386 1 5879661; fax: +386 1 5879304.
    • ,
  • J. Ocvirk

      Affiliations

    • Department of Medical Oncology, Institute of Oncology, Ljubljana, Slovenia
    • ,
  • I. Oblak

      Affiliations

    • Department of Radiotherapy, Institute of Oncology, Ljubljana, Slovenia
    • ,
  • F. Anderluh

      Affiliations

    • Department of Radiotherapy, Institute of Oncology, Ljubljana, Slovenia

Accepted 7 December 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0748-7983(09)00543-5

doi:10.1016/j.ejso.2009.12.002

European Journal of Surgical Oncology
Volume 36, Issue 3 , Pages 244-250, March 2010

Article Tools

* Image Usage & Resolution